Document Detail


Impact of post-operative hormone replacement therapy on life quality and prognosis in patients with ovarian malignancy.
MedLine Citation:
PMID:  22740889     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The present study aimed to assess the impact of post-surgical hormone replacement therapy (HRT) on life quality and prognosis in women with ovarian malignancy. HRT (Premarin, Nilestriol and medroxyprogesterone) was administered following surgery in 31 patients with ovarian cancer. A total of 44 ovarian cancer patients of similar age, clinical stage and pathological features did not receive HRT following surgery. The expression of estrogen receptor (ER)-α, ERβ and progesterone receptor (PR) in cancer tissues was detected by immunohistochemical staining. Serum levels of calcitonin (CT) and transforming growth factor (TGF)-α were determined by radioimmunoassay and enzyme-linked immunosorbent assay, respectively. Data were analyzed using Kaplan-Meier survival curves, a log-rank test and a Cox scale risk model. Quality of life was assessed in the patient groups and in healthy post-menopausal women (control) based on a questionnaire developed by the European Organization of Research and Treatment of Cancer (EORTC-C30), as well as our own specific questionnaire. A log-rank test revealed no difference in survival between the patients with and without HRT (p>0.05), and a Cox model showed that HRT was not an independent prognostic factor. The accumulated survival rate did not differ significantly based on the expression of ERα, ERβ or PR in patients with or without HRT (p>0.05). The serum TGFα levels prior to and following surgery were not significantly different in either of the two patient groups (p>0.05). Serum CT levels were higher in patients without HRT at 1.5 years following surgery (p<0.05), but no significant difference was found in the serum CT levels of patients receiving HRT. The HRT and non-HRT groups differed significantly with regard to the body and emotional functional sub-scales of the EORTC-C30 (p<0.05) and the sex quality and autonomic nerve maladjustment categories of our specific questionnaire (p<0.05). Findings of this study showed that HRT administered following surgery exhibited no apparent negative effect on prognosis in patients with ovarian cancer, regardless of ERα, ERβ or PR expression in cancer tissues, and had no effect on serum transforming growth factor (TGF)-α levels. Post-surgical HRT aided in the stabilization of serum CT levels and improved the quality of life in these patients.
Authors:
Li Li; Zhongmian Pan; Kun Gao; Wei Zhang; Yuan Luo; Zhongqiang Yao; Xinqiang Liang; Bujian Tang; Qingdi Quentin Li
Related Documents :
18799019 - Metabolite profiling of human colon carcinoma--deregulation of tca cycle and amino acid...
22313319 - The initial cancer pathway for children - one forth wait more than three months.
23581819 - Psma-targeted dendrimers: a patent evaluation (wo2012078534).
9464459 - Drug-metabolizing enzymes in pharyngeal mucosa and in oropharyngeal cancer tissue.
22476839 - Laparoscopic versus open colorectal resections in patients with symptomatic stage iv co...
15314949 - Metallothioneins and microelements in brain tumours.
22606589 - Basidiobolomycosis of the colon masquerading as stenotic colon cancer.
20176049 - Molecular therapeutic approaches to melanoma.
20970309 - Clinical significance of cd133 and hypoxia inducible factor-1α gene expression in rect...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-25
Journal Detail:
Title:  Oncology letters     Volume:  3     ISSN:  1792-1082     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-6-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101531236     Medline TA:  Oncol Lett     Country:  -    
Other Details:
Languages:  ENG     Pagination:  244-249     Citation Subset:  -    
Affiliation:
Department of Gynecologic Oncology, Cancer Hospital, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Differences between oral cancer and cancers of the pharynx and larynx on a molecular level.
Next Document:  Multifocal epithelial hyperplasia: A potentially precancerous disease? (Review).